News

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

BioNTech settles Covid-19 patent dispute with CureVac

BioNTech has agreed to pay UK drugmaker GSK royalties on its Covid-19 and influenza vaccines as part of a patent settlement with CureVac, in a deal that allows the biotech to move forward with the ...

CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech

German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...
Scientific American13h

Why mRNA Vaccines Are So Revolutionary—And What’s at Stake if We Lose Them

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

HHS phases out mRNA vaccine trials for COVID-19, bird flu

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
McKnight's Long-Term Care News1d

HHS makes mRNA vaccine project cuts as booster fatigue marks changing public attitude toward shots

On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a ...

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...